Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
The transcriptional role of cMyc (or Myc) in tumorigenesis is well appreciated; however, it remains to be fully established how extensively Myc is involved in the epigenetic regulation of gene expression. Here, we show that by deactivating succinate dehydrogenase complex subunit A (SDHA) via acetylation, Myc triggers a regulatory cascade in cancer cells that leads to H3K4me3 activation and gene expression. We find that Myc facilitates the acetylation-dependent deactivation of SDHA by activating the SKP2-mediated degradation of SIRT3 deacetylase. We further demonstrate that Myc inhibition of SDH-complex activity leads to cellular succinate accumulation, which triggers H3K4me3 activation and tumour-specific gene expression. We demonstrate that acetylated SDHA at Lys 335 contributes to tumour growth in vitro and in vivo, and we confirm increased tumorigenesis in clinical samples. This study illustrates a link between acetylation-dependent SDHA deactivation and Myc-driven epigenetic regulation of gene expression, which is critical for cancer progression.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Nature metabolism - 2(2020), 3 vom: 22. März, Seite 256-269 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Shi-Ting [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AB6MNQ6J6L |
|---|
| Anmerkungen: |
Date Completed 06.01.2021 Date Revised 16.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s42255-020-0179-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312709692 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312709692 | ||
| 003 | DE-627 | ||
| 005 | 20231225145011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s42255-020-0179-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1042.xml |
| 035 | |a (DE-627)NLM312709692 | ||
| 035 | |a (NLM)32694775 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Shi-Ting |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.01.2021 | ||
| 500 | |a Date Revised 16.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The transcriptional role of cMyc (or Myc) in tumorigenesis is well appreciated; however, it remains to be fully established how extensively Myc is involved in the epigenetic regulation of gene expression. Here, we show that by deactivating succinate dehydrogenase complex subunit A (SDHA) via acetylation, Myc triggers a regulatory cascade in cancer cells that leads to H3K4me3 activation and gene expression. We find that Myc facilitates the acetylation-dependent deactivation of SDHA by activating the SKP2-mediated degradation of SIRT3 deacetylase. We further demonstrate that Myc inhibition of SDH-complex activity leads to cellular succinate accumulation, which triggers H3K4me3 activation and tumour-specific gene expression. We demonstrate that acetylated SDHA at Lys 335 contributes to tumour growth in vitro and in vivo, and we confirm increased tumorigenesis in clinical samples. This study illustrates a link between acetylation-dependent SDHA deactivation and Myc-driven epigenetic regulation of gene expression, which is critical for cancer progression | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Proto-Oncogene Proteins c-myc |2 NLM | |
| 650 | 7 | |a Succinic Acid |2 NLM | |
| 650 | 7 | |a AB6MNQ6J6L |2 NLM | |
| 650 | 7 | |a Electron Transport Complex II |2 NLM | |
| 650 | 7 | |a EC 1.3.5.1 |2 NLM | |
| 650 | 7 | |a SDHA protein, human |2 NLM | |
| 650 | 7 | |a EC 1.3.5.1 |2 NLM | |
| 700 | 1 | |a Huang, De |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Shengqi |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Yongping |e verfasserin |4 aut | |
| 700 | 1 | |a Xing, Songge |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Gongwei |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Zetan |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Yijie |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Mengqiu |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Nana |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Lianbang |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Ronghui |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Dongdong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Zhaoji |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Rongbin |e verfasserin |4 aut | |
| 700 | 1 | |a Qu, Kun |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Ailing |e verfasserin |4 aut | |
| 700 | 1 | |a Duan, Xiaotao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Huafeng |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Ping |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature metabolism |d 2019 |g 2(2020), 3 vom: 22. März, Seite 256-269 |w (DE-627)NLM295098996 |x 2522-5812 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:3 |g day:22 |g month:03 |g pages:256-269 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s42255-020-0179-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 3 |b 22 |c 03 |h 256-269 | ||